These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2890254)

  • 21. Almitrine has no effect on gas exchange after bilateral carotid body resection in severe chronic airflow obstruction.
    De Backer W; Vermeire P; Bogaert E; Janssens E; Van Maele R
    Bull Eur Physiopathol Respir; 1985; 21(5):427-32. PubMed ID: 3904873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neuropathy caused by almitrine].
    Mizon JP; Rosa A; Sevestre H
    Therapie; 1986; 41(2):149. PubMed ID: 2873664
    [No Abstract]   [Full Text] [Related]  

  • 23. [Almitrine: a peripheral respiratory stimulant in chronic obstructive pulmonary disease].
    Rubio Terrés C; López Alvarez M; Vargas Castrillón E
    Rev Clin Esp; 1990 Feb; 186(2):84-7. PubMed ID: 2158666
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Almitrine per os in the therapy of chronic obstructive bronchopneumopathies].
    Seignalet C; Préfaut C; Gonzales C; Michel FB
    Rev Fr Mal Respir; 1980; 8(6):627-33. PubMed ID: 7027375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is chronic hypoxaemia and/or hypercapnia of the obstructive patient reversible? The role of almitrine bismesylate.
    Eur J Respir Dis Suppl; 1986; 146():609-718. PubMed ID: 2877898
    [No Abstract]   [Full Text] [Related]  

  • 26. One year administration of almitrine bismesylate (Vectarion) to chronic obstructive pulmonary disease patients: pharmacokinetic analysis.
    Stavchansky S; Doluisio JT; Macleod CM; Szalkowski MB; Bachand RT; Heilman R; Sebree TB; Geary RS
    Biopharm Drug Dispos; 1989; 10(3):247-55. PubMed ID: 2566339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pulmonary hemodynamic monitoring in chronic respiratory insufficiency treated with almitrine bismesilate for 4 months in a double-blind study].
    Bourgouin-Karaouni D; Ramonatxo M; Michel FB; Macabies J; Prefaut C
    Rev Mal Respir; 1984; 1(4):245-50. PubMed ID: 6505362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lung function and blood gas analysis studies in patients with COPD and respiratory insufficiency receiving almitrine medication with special reference to its clinical aspects].
    Hillebrand M; Siemon G
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():391-3. PubMed ID: 2902610
    [No Abstract]   [Full Text] [Related]  

  • 29. Lung function after almitrine bismesylate administration in a five year old boy with chronic airways obstruction.
    Gaultier C; Boule M; Mercier JC; Beaufils F
    Eur J Respir Dis Suppl; 1983; 126():319-21. PubMed ID: 6426995
    [No Abstract]   [Full Text] [Related]  

  • 30. Peripheral neuropathy in chronic respiratory insufficiency.
    Jann S; Gatti A; Crespi S; Rolo J; Beretta S
    J Peripher Nerv Syst; 1998; 3(1):69-74. PubMed ID: 10959240
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical pharmacokinetics of almitrine dimesylate].
    Bromet N; Singlas E
    Presse Med; 1984 Oct; 13(34):2071-7. PubMed ID: 6149534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Misonidazole Neuropathy: a clinical, electrophysiological, and histological study.
    Melgaard B; Hansen HS; Kamieniecka Z; Paulson OB; Pedersen AG; Tang X; Trojaborg W
    Ann Neurol; 1982 Jul; 12(1):10-7. PubMed ID: 7114817
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of almitrine bismesylate on arterial blood gases and ventilatory drive in patients with severe chronic airflow obstruction and bilateral carotid body resection.
    de Backer W; Bogaert E; Van Maele R; Vermeire P
    Eur J Respir Dis Suppl; 1983; 126():239-42. PubMed ID: 6426993
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Degenerative neuromuscular diseases with a late onset. Clinical, electrophysiological and morphological study.
    Voiculescu V; Alexianu M; Dan A; Manole E; Ionescu MD; Burghelea B; Zlătescu NC
    Rom J Neurol Psychiatry; 1994; 32(1):43-55. PubMed ID: 8038097
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral neuropathies during treatment with almitrine: report of 46 cases.
    Bouche P; Lacomblez L; Leger JM; Chaunu MP; Ratinahirana H; Brunet P; Hauw JJ; Cathala HP; Laplane D
    J Neurol; 1989 Jan; 236(1):29-33. PubMed ID: 2536801
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of hematosis disorders in chronic obstructive bronchitis with almitrine bismesylate].
    González Montaner LJ
    Medicina (B Aires); 1986; 46(6):739-41. PubMed ID: 3306258
    [No Abstract]   [Full Text] [Related]  

  • 37. Beneficial effects of almitrine bismesylate on pulmonary gas exchange in COPD.
    Melot C; Naeije R; Hallemans R; Mols P; Lejeune P
    Eur J Respir Dis Suppl; 1983; 126():249-54. PubMed ID: 6586439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of almitrine, a chemoreceptor stimulator, on nocturnal hypercapnia and pulmonary artery pressure during O2 respiration in chronic obstructive lung disease].
    Rühle KH; Kempf P; Mössinger B; Klein G; Costabel U; Würtemberger G; Matthys H
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():411-4. PubMed ID: 2902613
    [No Abstract]   [Full Text] [Related]  

  • 39. [Range of neuromuscular involvement in 47 patients infected with the human immunodeficiency virus].
    Ghika-Schmid F; Kuntzer T; Chave JP; Miklossy J; Regli F
    Schweiz Med Wochenschr; 1994 May; 124(19):791-800. PubMed ID: 8209201
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Almitrine bismesylate: current status.
    Tweney J
    Bull Eur Physiopathol Respir; 1987 Aug; 23 Suppl 11():153s-163s. PubMed ID: 3318970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.